Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma
Modern Pathology2007Vol. 20(10), pp. 1028–1035
Citations Over TimeTop 10% of 2007 papers
Lynette M. Sholl, A. John Iafrate, Yi-Ping Chou, Ming‐Tsang Wu, Yih‐Gang Goan, Li Su, Yen‐Tsung Huang, David C. Christiani, Lucian R. Chirieac
Related Papers
- → Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma(2007)50 cited
- → Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens(2007)55 cited
- → Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)(2012)42 cited
- → Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer(2010)16 cited
- → Assessment of HER2/neu status in breast cancer: a comparison of immunohistochemistry, fluorescence insitu hybridization and chromogenic insitu hybridization(2008)